CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation

Stable Identifier
R-HSA-211910
Type
Reaction [transition]
Species
Homo sapiens
Compartment
endoplasmic reticulum membrane, endoplasmic reticulum lumen
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Paclitaxel (Taxol) is a naturally occurring member of the taxane family of antitumor drugs. It acts by stabilizing microtubules. Paclitaxel is inactivated in human liver by CYP2C8, which catalyzes 6alpha-hydroxylation of paclitaxel.
Literature References
PubMed ID Title Journal Year
9842986 Human liver microsomal metabolism of paclitaxel and drug interactions

Desai, PB, Duan, JZ, Zhu, YW, Kouzi, S

Eur J Drug Metab Pharmacokinet 1998
Participants
Input
Output
Participates
as an event of
Catalyst Activity

monooxygenase activity of Cytochrome P450 (CYP2C8 based) [endoplasmic reticulum membrane]

Physical Entity
Cytochrome P450 (CYP2C8 based) [endoplasmic reticulum membrane] (Homo sapiens)
Activity
monooxygenase activity (GO:0004497)
Orthologous Events
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Bos taurus)
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Caenorhabditis elegans)
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Dictyostelium discoideum)
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Mus musculus)
CYP2C8 inactivates paclitaxel by 6alpha-hydroxylation (Rattus norvegicus)
Authored
Jassal, B  (2008-05-19)
Reviewed
D'Eustachio, P  (2008-05-28)
Created
Jassal, B  (2008-02-08)
Cite Us!